Bioimaging

 Table of Content
1. SCOPE AND METHODOLOGY
2. REPORT SYNOPSIS
2.1 Introduction
Bioimaging
Medical Imaging
Molecular Imaging
2.2 Segmentation of Bioimaging
Exhibit 1. Segmentation of Global Bioimaging Market by Application and Modalities
Application
Diagnostics
Research and Development
Modalities
Ultrasound
CT
MRI
PET
SPECT
2.3 Bioimaging - Global Market Analysis
Exhibit 2. Bioimaging – Global Market Estimations & Predictions (2005 – 2020) in US$ Billion (Graphical Representation Included)
Exhibit 3. List of Global Major Bioimaging Companies
3. MARKET DYNAMICS
3.1 Market Overview
Bioimaging - A Prominent Advancement in the Field of Biomedical Research
Medical Imaging and its Prospective Role in Pharmaceutical Clinical Trials
Whole Body Imaging
3.2 Global Bioimaging Market
Exhibit 4.: Bioimaging – Global Market Estimations & Predictions (2005 – 2020) by Geographic Region for North America, Europe, Asia-Pacific, Latin America and Rest of World in US$ Billion (Graphical Representation Included)
Exhibit 5.: Bioimaging – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific, Latin America and Rest of World (RoW) (Graphical Representation Included)
3.3 North American Bioimaging Market
Exhibit 6. Bioimaging – North American Market Estimations & Predictions (2005 – 2020) by Country for the United States and Canada in US$ Million (Graphical Representation Included)
Exhibit 7. Bioimaging – North American Market Shares (2010, 2015 & 2020) by Country for the United States and Canada (Graphical Representation Included)
3.3 (I) US Bioimaging Market
3.3 (II) Canadian Bioimaging Market
Exhibit 8. List of Major North American Bioimaging Companies
3.4 European Bioimaging Market
Exhibit 9. Bioimaging – European Market Estimations & Predictions (2005 – 2020) by Country for Germany, United Kingdom, France, Italy, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 10. Bioimaging – European Market Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, France, Italy, Russia and Rest of Europe (Graphical Representation Included)
3.4 (I) German Bioimaging Market
3.4 (II) UK Bioimaging Market
3.4 (III) French Bioimaging Market
3.5 (IV) Italian Bioimaging Market
3.5 (V) Russian Bioimaging Market
Exhibit 11. List of Major European Bioimaging Companies
3.5 Asia-Pacific Bioimaging Market
Exhibit 12. Bioimaging – Asia-Pacific Market Estimations & Predictions (2005 – 2020) by Country for Australia, China, India, Japan, South Korea and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Exhibit 13. Bioimaging – Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Australia, China, India, Japan, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
3.5 (I) Australian Bioimaging Market
3.5 (II) Chinese Bioimaging Market
3.5 (III) Indian Bioimaging Market
3.5 (II) Japanese Bioimaging Market
3.5 (III) South Korean Bioimaging Market
Exhibit 14. List of Major Asia-Pacific Bioimaging Companies
3.6 Latin American Bioimaging Market
Exhibit 15. Bioimaging – Bioimaging – Latin America Market Estimations & Predictions (2005-2020) by Country for Brazil, Mexico and Rest of Latin America in US$ Million (Graphical Representation Included)
Exhibit 16. Bioimaging – Latin American Market Shares (2010, 2015 & 2020) by Country for Brazil, Mexico and Rest of Latin America (Graphical Representation Included)
3.6 (I) Brazilian Bioimaging Market
3.6 (II) Mexican Bioimaging Market
Exhibit 17. List of Major Latin-American Bioimaging Companies
3.7 Rest of World Bioimaging Market
Exhibit 18. Bioimaging – Rest of World Market Estimations & Predictions (2005-2020) by Country for Israel, South Africa and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 19. Bioimaging – Rest of World Market Shares (2010, 2015 & 2020) by Country for Israel, South Africa and Other Countries (Graphical Representation Included)
3.7 (I) Israeli Bioimaging Market
3.7 (II) South African Bioimaging Market
Exhibit 20. List of Major Rest of World Bioimaging Companies
3.8 Market Trends
Focus of Bioimaging
Future of Bioimaging
Bioimaging - Present and Future
Less Invasive Mammography
Looking into the Brain
Pocket – size Ultrasound
3.9 Major Global Companies in Bioimaging Industry
Analogic Corporation (USA)
Arcoma AB (Sweden)
Bayer HealthCare AG (Germany)
Bracco SpA (Italy)
Carestream Health, Inc. (USA)
Carl Zeiss Meditec AG (Germany)
Cell>Point LLC (USA)
Digirad Corporation (USA)
Esaote SpA (Italy)
FEI Company (USA)
FONAR Corporation (USA)
FUJIFILM SonoSite, Inc. (USA)
FUJIFILM VisualSonics, Inc. (Canada)
Gamma Medica, Inc. (USA)
GE Healthcare Ltd. (UK)
Guerbet SA (France)
Hitachi Medical Corporation (Japan)
Hologic, Inc. (USA)
Jubilant DraxImage, Inc. (Canada)
Kereos, Inc. (USA)
Koninklijke Philips Electronics N.V. (The Netherlands)
Lantheus Medical Imaging (USA)
Mallinckrodt plc (Ireland)
Mindray Bio-Medical Electronics Co., Ltd. (China)
Neusoft Group Ltd. (China)
Positron Corporation (USA)
Samsung Medison Co., Ltd. (South Korea)
Shimadzu Corporation (Japan)
Siemens Medical Solutions, Inc. (USA)
Swissray Medical AG (Switzerland)
Toshiba Medical Systems Corporation (Japan)
Varian Medical Systems, Inc. (USA)
3.10 Major Activities in Bioimaging Industry
Medtronic Completes Acquisition of Covidien
FujiFilm VisualSonics Collaborates with inviCRO
Varian Medical Plans to Acquire MeVis Medical Solutions
Lantheus Medical Imaging and SHINE Medical Enters into Mo-99 Supply Agreement
Vital Unveils VitreaExtend™ Under Vitrea® Enterprise Range
TMS Establishes New Production Unit in Malaysia
More……
3.11 Major Product Innovations/Launches in Bioimaging Industry
Gadavist® Approved by FDA for Infant Patients Less Than 2 Years
Shimadzu Unveils a Compact RADspeed fit General Radiography System
Bracco Diagnostics’s US FDA Approved Multi-Dose Compliant Contrast Medium Brings Advanced Solution for POC CT Application
Bracco Diagnostics Gains Approval for New Ultrasound Contrast Agent from the US FDA
Analogic Launches Flex Focus 400 exp Ultrasound System
More……
3.12 Analysis by Application
Exhibit 21. Bioimaging by Application – Global Market Estimations & Predictions (2005 – 2020) for Diagnostics and Research and Development in US$ Billion (Graphical Representation Included)
Exhibit 22. Bioimaging by Application – Global Market Shares (2010, 2015 & 2020) for Diagnostics and Research and Development (Graphical Representation Included)
3.12.1 Diagnostics
3.12.1.1 Global Market for Bioimaging in Diagnostics
Exhibit 23. Bioimaging in Diagnostics – Global Market Estimations & Predictions (2005 – 2020) by Geographic Region for North America, Europe, Asia-Pacific, Latin America and Rest of World (RoW) in US$ Billion (Graphical Representation Included)
Exhibit 24. Bioimaging in Diagnostics – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific, Latin America and Rest of World (RoW) (Graphical Representation Included)
3.12.1.2 North American Market for Bioimaging in Diagnostics
Exhibit 25. Bioimaging in Diagnostics – North American Market Estimations & Predictions (2005 – 2020) by Country for the United States and Canada in US$ Million (Graphical Representation Included)
Exhibit 26. Bioimaging in Diagnostics – North American Market Shares (2010, 2015 & 2020) by Country for the United
States and Canada (Graphical Representation Included)
3.12.1.2 (I) US Market for Bioimaging in Diagnostics
3.12.1.2 (II) Canadian Market for Bioimaging in Diagnostics
3.12.1.3 European Market for Bioimaging in Diagnostics
Exhibit 27. Bioimaging in Diagnostics – European Market Estimations & Predictions (2005 – 2020) by Country for Germany, United Kingdom, France, Italy, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 28. Bioimaging in Diagnostics – European Market Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, France, Italy, Russia and Rest of Europe (Graphical Representation Included)
3.12.1.3 (I) German Market for Bioimaging in Diagnostics
3.12.1.3 (II) UK Market for Bioimaging in Diagnostics
3.12.1.3 (III) French Market for Bioimaging in Diagnostics
3.12.1.3 (IV) Italian Market for Bioimaging in Diagnostics
3.12.1.3 (V) Russian Market for Bioimaging in Diagnostics
3.12.1.4 Asia-Pacific Market for Bioimaging in Diagnostics
Exhibit 29. Bioimaging in Diagnostics – Asia-Pacific Market Estimations & Predictions (2005-2020) in US$ Million by Country for Australia, China, India, Japan, South Korea and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Exhibit 30. Bioimaging in Diagnostics – Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Australia, China, India, Japan, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
3.12.1.4 (I) Australian Market for Bioimaging in Diagnostics
3.12.1.4 (II) Chinese Market for Bioimaging in Diagnostics
3.12.1.4 (III) Indian Market for Bioimaging in Diagnostics
3.12.1.4 (IV) Japanese Market for Bioimaging in Diagnostics
3.12.1.4 (V) South Korean Market for Bioimaging in Diagnostics
3.12.1.5 Latin American Market for Bioimaging in Diagnostics
Exhibit 31. Bioimaging in Diagnostics – Latin American Market Estimations & Predictions (2005 – 2020) by Country for Brazil, Mexico and Rest of Latin America in US$ Million (Graphical Representation Included)
Exhibit 32. Bioimaging in Diagnostics – Latin American Market Shares (2010, 2015 & 2020) by Country for Brazil, Mexico and Rest of Latin America (Graphical Representation Included)
3.12.1.5 (I) Brazilian Market for Bioimaging in Diagnostics
3.12.1.5 (II) Mexican Market for Bioimaging in Diagnostics
3.12.1.6 Rest of World Market for Bioimaging in Diagnostics Market
Exhibit 33. Bioimaging in Diagnostics – Rest of World Market Estimations & Predictions (2005-2020) by Country for Israel, South Africa and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 34. Bioimaging in Diagnostics – Rest of World Market Shares (2010, 2015 & 2020) by Country for Israel, South
Africa and Other Countries (Graphical Representation Included)
3.12.1.6 (I) Israeli Market for Bioimaging in Diagnostics
3.12.1.6 (II) South African Market for Bioimaging in Diagnostics
3.12.2 Research and Development
3.12.2.1 Global Market for Bioimaging in Research and Development
Exhibit 35. Bioimaging in Research and Development – Global Market Estimations & Predictions (2005 – 2020) by Geographic Region for North America, Europe, Asia-Pacific, Latin America and Rest of World (RoW) in US$ Billion (Graphical Representation Included)
Exhibit 36. Bioimaging in Research and Development – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific, Latin America and Rest of World (RoW) (Graphical Representation Included)
3.12.2.2 North American Market Bioimaging in Research and Development
Exhibit 37. Bioimaging in Research and Development – North American Market Estimations & Predictions (2005 – 2020) by Country for the United States and Canada in US$ Million (Graphical Representation Included)
Exhibit 38. Bioimaging in Research and Development – North American Market Shares (2010, 2015 & 2020) by Country for the United States and Canada (Graphical Representation Included)
3.12.2.2 (I) US Market for Bioimaging in Research and Development
3.12.2.2 (II) Canadian Market Bioimaging in Research and Development
3.12.2.3 European Market for Bioimaging in Research and Development
Exhibit 39. Bioimaging in Research and Development – European Market Estimations & Predictions (2005 – 2020) by Country for Germany, United Kingdom, France, Italy, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 40. Bioimaging in Research and Development – European Market Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, France, Italy, Russia and Rest of Europe (Graphical Representation Included)
3.12.2.3 (I) German Market for Bioimaging in Research and Development
3.12.2.3 (II) UK Market for Bioimaging in Research and Development
3.12.2.3 (III) French Market for Bioimaging in Research and Development
3.12.2.3 (IV) Italian Market for Bioimaging in Research and Development
3.12.2.3 (V) Russian Market for Bioimaging in Research and Development
3.12.2.4 Asia-Pacific Market for Bioimaging in Research and Development
Exhibit 41. Bioimaging in Research and Development – Asia-Pacific Market Estimations & Predictions (2005-2020) in US$ Million by Country for Australia, China, India, Japan, South Korea and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Exhibit 42. Bioimaging in Research and Development – Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Australia, China, India, Japan, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
3.12.2.4 (I) Australian Market for Bioimaging in Research and Development
3.12.2.4 (II) Chinese Market for Bioimaging in Research and Development
3.12.2.4 (III) Indian Market for Bioimaging in Research and Development
3.12.2.4 (IV) Japanese Market for Bioimaging in Research and Development
3.12.2.4 (V) South Korean Market for Bioimaging in Research and Development
3.12.2.5 Latin American Market for Bioimaging in Research and Development
Exhibit 43. Bioimaging in Research and Development – Latin American Market Estimations & Predictions (2005 – 2020) by Country for Brazil, Mexico and Rest of Latin America in US$ Million (Graphical Representation Included)
Exhibit 44. Bioimaging in Research and Development – Latin American Market Shares (2010, 2015 & 2020) by Country for Brazil, Mexico and Rest of Latin America (Graphical Representation Included)
3.12.2.6 Rest of World Market for Bioimaging in Research and Development
Exhibit 45. Bioimaging in Research and Development – Rest of World Market Estimations & Predictions (2005-2020) by Country for Israel, South Africal and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 46. Bioimaging in Research and Development – Rest of World Market Shares (2010, 2015 & 2020) by Country for Israel, South Africa and Other Countries (Graphical Representation Included)
3.13 Analysis by Modalities
Exhibit 47. Bioimaging by Modalities – Global Market Estimations & Predictions (2005 – 2020) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Billion (Graphical Representation Included)
Exhibit 48. Bioimaging by Modalities – Global Market Shares (2010, 2015 & 2020) for Ultrasound, CT, MRI, PET, SPECT and Other (Graphical Representation Included)
3.13.1 Ultrasound
3.13.1.1 Global Ultrasound Bioimaging Market
Exhibit 49. Ultrasound Bioimaging – Global Market Estimations & Predictions (2005 –2020) by Geographic Region for North America, Europe, Asia-Pacific, Latin America and Rest of World (RoW) in US$ Million (Graphical Representation Included)
Exhibit 50. Ultrasound Bioimaging – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific, Latin America and Rest of World (RoW) (Graphical Representation Included)
3.13.1.2 North American Ultrasound Bioimaging Market
Exhibit 51. Ultrasound Bioimaging – North American Market Estimations & Predictions (2005 – 2020) by Country for the United States and Canada in US$ Million (Graphical Representation Included)
Exhibit 52. Ultrasound Bioimaging – North American Market Shares (2010, 2015 & 2020) by Country for the United States and Canada (Graphical Representation Included)
3.13.1.2 (I) US Ultrasound Bioimaging Market
3.13.1.2 (II) Canadian Ultrasound Bioimaging Market
Exhibit 53. List of Major North American Ultrasound Bioimaging Companies
3.13.1.3 European Ultrasound Bioimaging Market
Exhibit 54. Ultrasound Bioimaging – European Market Estimations & Predictions (2005 – 2020) by Country for Germany, United Kingdom, France, Italy, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 55. Ultrasound Bioimaging – European Market Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, France, Italy, Russia and Rest of Europe (Graphical Representation Included)
3.13.1.3 (I) German Ultrasound Bioimaging Market
3.13.1.3 (II) UK Ultrasound Bioimaging Market
3.13.1.3 (III) French Ultrasound Bioimaging Market
3.13.1.3 (IV) Italian Ultrasound Bioimaging Market
3.13.1.3 (V) Russian Ultrasound Bioimaging Market
Exhibit 56. List of Major European Ultrasound Bioimaging Companies
3.13.1.4 Asia-Pacific Ultrasound Bioimaging Market
Exhibit 57. Ultrasound Bioimaging – Asia-Pacific Market Estimations & Predictions (2005-2020) in US$ Million by Country for Australia, China, India, Japan, South Korea and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Exhibit 58. Ultrasound Bioimaging – Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Australia, China, India, Japan, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
3.13.1.4 (I) Australian Ultrasound Bioimaging Market
3.13.1.4 (II) Chinese Ultrasound Bioimaging Market
3.13.1.4 (III) Indian Ultrasound Bioimaging Market
3.13.1.4 (IV) Japanese Ultrasound Bioimaging Market
3.13.1.4 (V) South Korean Ultrasound Bioimaging Market
3.13.1.5 Latin American Ultrasound Bioimaging Market
Exhibit 59. Ultrasound Bioimaging – Latin American Market Estimations & Predictions (2005 – 2020) by Country for Brazil, Mexico and Rest of Latin America in US$ Million (Graphical Representation Included)
Exhibit 60. Ultrasound Bioimaging – Latin American Market Shares (2010, 2015 & 2020) by Country for Brazil, Mexico and Rest of Latin America (Graphical Representation Included)
3.13.1.5 (I) Brazilian Ultrasound Bioimaging Market
3.13.1.5 (II) Mexican Ultrasound Bioimaging Market
3.13.1.6 Rest of World Ultrasound Bioimaging Market
Exhibit 61. Ultrasound Bioimaging – Rest of World Market Estimations & Predictions (2005-2020) by Country for Israel, South African, and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 62. Ultrasound Bioimaging – Rest of World Market Shares (2010, 2015 & 2020) by Country for Israel, South African, and Other Countries (Graphical Representation Included)
3.13.1.6 (I) Israeli Ultrasound Bioimaging Market
3.13.1.6 (II) South African Ultrasound Bioimaging Market
Exhibit 63. List of Major Rest of World Ultrasound Bioimaging Companies
3.13.2 CT (Computed Tomography)
3.13.2.1 Global CT Bioimaging Market
Exhibit 64. CT Bioimaging – Global Market Estimations & Predictions (2005 – 2020) by Geographic Region for North America, Europe, Asia-Pacific, Latin America and Rest of World (RoW) in US$ Million (Graphical Representation Included)
Exhibit 65. CT Bioimaging – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific, Latin America and Rest of World (RoW) (Graphical Representation Included)
3.13.2.2 North American CT Bioimaging Market
Exhibit 66. CT Bioimaging – North American Market Estimations & Predictions (2005 – 2020) by Country for the United States and Canada in US$ Million (Graphical Representation Included)
Exhibit 67. CT Bioimaging – North American Market Shares (2010, 2015 & 2020) by Country for the United States and Canada (Graphical Representation Included)
3.13.2.2 (I) US CT Bioimaging Market
3.13.2.2 (II) Canadian CT Bioimaging Market
Exhibit 68. List of Major North American CT Bioimaging Companies
3.13.2.3 European CT Bioimaging Market
Exhibit 69. CT Bioimaging – European Market Estimations & Predictions (2005 – 2020) by Country for Germany, United Kingdom, France, Italy, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 70. CT Bioimaging – European Market Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, France, Italy, Russia and Rest of Europe (Graphical Representation Included)
3.13.2.3 (I) German CT Bioimaging Market
3.13.2.3 (II) UK CT Bioimaging Market
3.13.2.3 (III) French CT Bioimaging Market
3.13.2.3 (IV) Italian CT Bioimaging Market
3.13.2.3 (V) Russian CT Bioimaging Market
Exhibit 71. List of Major European CT Bioimaging Companies
3.13.2.4 Asia-Pacific CT Bioimaging Market
Exhibit 72. CT Bioimaging – Asia-Pacific Market Estimations & Predictions (2005-2020) in US$ Million by Country for Australia, China, India, Japan, South Korea and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Exhibit 73. CT Bioimaging – Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Australia, China, India, Japan, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
3.13.2.4 (I) Australian CT Bioimaging Market
3.13.2.4 (II) Chinese CT Bioimaging Market
3.13.2.4 (III) Indian CT Bioimaging Market
3.13.2.4 (IV) Japanese CT Bioimaging Market
3.13.2.4 (V) South Korean CT Bioimaging Market
Exhibit 74. List of Major Asia-Pacific CT Bioimaging Companies
3.13.2.5 Latin America CT Bioimaging Market
Exhibit 75. CT Bioimaging – Latin American Market Estimations & Predictions (2005 – 2020) by Country for Brazil, Mexico and Rest of Latin America in US$ Million (Graphical Representation Included)
Exhibit 76. CT Bioimaging – Latin American Market Shares (2010, 2015 & 2020) by Country for Brazil, Mexico and Rest of Latin America (Graphical Representation Included)
3.13.2.5 (I) Brazilian CT Bioimaging Market
3.13.2.5 (II) Mexican CT Bioimaging Market
Exhibit 77. List of Major Latin-America CT Bioimaging Companies
3.13.2.6 Rest of World CT Bioimaging Market
Exhibit 78. CT Bioimaging – Rest of World Market Estimations & Predictions (2005-2020) by Country for Israel, South Africa and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 79. CT Bioimaging – Rest of World Market Shares (2010, 2015 & 2020) by Country for Israel, South Africa and Other Countries (Graphical Representation Included)
3.13.2.6 (I) Israeli CT Bioimaging Market
3.13.2.6 (II) South African CT Bioimaging Market
Exhibit 80. List of Major Rest of World CT Bioimaging Companies
3.13.3 MRI (Manetic Resonance Imaging)
3.13.3.1 Global MRI Bioimaging Market
Exhibit 81. MRI Bioimaging – Global Market Estimations & Predictions (2005 – 2020) by Geographic Region for North America, Europe, Asia-Pacific, Latin America and Rest of World (RoW) in US$ Million (Graphical Representation Included)
Exhibit 82. MRI Bioimaging – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific, Latin America and Rest of World (RoW) (Graphical Representation Included)
3.13.3.2 North American MRI Bioimaging Market
Exhibit 83. MRI Bioimaging – North American Market Estimations & Predictions (2005 – 2020) by Country for the United States and Canada in US$ Million (Graphical Representation Included)
Exhibit 84. MRI Bioimaging – North American Market Shares (2010, 2015 & 2020) by Country for the United States and Canada (Graphical Representation Included)
3.13.3.2 (I) US MRI Bioimaging Market
3.13.3.2 (II) Canadian MRI Bioimaging Market
Exhibit 85. List of Major North American MRI Bioimaging Companies
3.13.3.3 European MRI Bioimaging Market
Exhibit 86. MRI Bioimaging – European Market Estimations & Predictions (2005 – 2020) by Country for Germany, United Kingdom, France, Italy, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 87. MRI Bioimaging – European Market Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, France, Italy, Russia and Rest of Europe (Graphical Representation Included)
3.13.3.3 (I) German MRI Bioimaging Market
3.13.3.3 (II) UK MRI Bioimaging Market
3.13.3.3 (III) French MRI Bioimaging Market
3.13.3.3 (IV) Italian MRI Bioimaging Market
3.13.3.3 (V) Russian MRI Bioimaging Market
Exhibit 88. List of Major European MRI Bioimaging Companies
3.13.3.4 Asia-Pacific MRI Bioimaging Market
Exhibit 89. MRI Bioimaging – Asia-Pacific Market Estimations & Predictions (2005-2020) in US$ Million by Country for Australia, China, India, Japan, South Korea and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Exhibit 90. MRI Bioimaging – Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Australia, China, India, Japan, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
3.13.3.4 (I) Australian MRI Bioimaging Market
3.13.3.4 (II) Chinese MRI Bioimaging Market
3.13.3.4 (III) Indian MRI Bioimaging Market
3.13.3.4 (IV) Japanese MRI Bioimaging Market
3.13.3.4 (V) South Korean MRI Bioimaging Market
Exhibit 91. List of Major Asia-Pacific MRI Bioimaging Companies
3.13.3.5 Latin America MRI Bioimaging Market
Exhibit 92. MRI Bioimaging – Latin American Market Estimations & Predictions (2005 – 2020) by Country for Brazil, Mexico and Rest of Latin America in US$ Million (Graphical Representation Included)
Exhibit 93. MRI Bioimaging – Latin American Market Shares (2010, 2015 & 2020) by Country for Brazil, Mexico and Rest of Latin America (Graphical Representation Included)
3.13.3.5 (I) Brazilian MRI Bioimaging Market
3.13.3.5 (II) Mexican MRI Bioimaging Market
Exhibit 94. List of Major Latin-America MRI Bioimaging Companies
3.13.3.6 Rest of World MRI Bioimaging Market
Exhibit 95. MRI Bioimaging – Rest of World Market Estimations & Predictions (2005-2020) by Country for Israel, South Africa and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 96. MRI Bioimaging – Rest of World Market Shares (2010, 2015 & 2020) by Country for Israel, South Africa and Other Countries (Graphical Representation Included)
3.13.3.6 (I) Israeli MRI Bioimaging Market
3.13.3.6 (II) South African MRI Bioimaging Market
Exhibit 97. List of Major Rest of World MRI Bioimaging Companies
3.13.4 PET (Positron Emission Tomography)
3.13.4.1 Global PET Bioimaging Market
Exhibit 98. PET Bioimaging – Global Market Estimations & Predictions (2005 – 2020) by Geographic Region for North America, Europe, Asia-Pacific, Latin America and Rest of World (RoW) in US$ Million (Graphical Representation Included)
Exhibit 99. PET Bioimaging – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific, Latin America and Rest of World (RoW) (Graphical Representation Included)
3.13.4.2 North American PET Bioimaging Market
Exhibit 100. PET Bioimaging – North American Market Estimations & Predictions (2005 – 2020) by Country for the United States and Canada in US$ Million (Graphical Representation Included)
Exhibit 101. PET Bioimaging – North American Market Shares (2010, 2015 & 2020) by Country for the United States and Canada (Graphical Representation Included)
3.13.4.2 (I) US PET Bioimaging Market
3.13.4.2 (II) Canadian PET Bioimaging Market
Exhibit 102. List of Major North American PET Bioimaging Companies
3.13.4.3 European PET Bioimaging Market
Exhibit 103. PET Bioimaging – European Market Estimations & Predictions (2005 – 2020) by Country for Germany, United Kingdom, France, Italy, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 104. PET Bioimaging – European Market Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, France, Italy, Russia and Rest of Europe (Graphical Representation Included)
3.13.4.3 (I) German PET Bioimaging Market
3.13.4.3 (II) UK PET Bioimaging Market
3.13.4.3 (III) French PET Bioimaging Market
3.13.4.3 (IV) Italian PET Bioimaging Market
3.13.4.3 (V) Russian PET Bioimaging Market
Exhibit 105. List of Major European PET Bioimaging Companies
3.13.4.4 Asia-Pacific PET Bioimaging Market
Exhibit 106. PET Bioimaging – Asia-Pacific Market Estimations & Predictions (2005-2020) in US$ Million by Country for Australia, China, India, Japan, South Korea and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Exhibit 107. PET Bioimaging – Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Australia, China, India, Japan, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
3.13.4.4 (I) Australian PET Bioimaging Market
3.13.4.4 (II) Chinese PET Bioimaging Market
3.13.4.4 (III) Indian PET Bioimaging Market
3.13.4.4 (IV) Japanese PET Bioimaging Market
3.13.4.4 (V) South Korean PET Bioimaging Market
Exhibit 108. List of Major Asia-Pacific PET Bioimaging Companies
3.13.4.5 Latin America PET Bioimaging Market
Exhibit 109. PET Bioimaging – Latin American Market Estimations & Predictions (2005 – 2020) by Country for Brazil, Mexico and Rest of Latin America in US$ Million (Graphical Representation Included)
Exhibit 110. PET Bioimaging – Latin American Market Shares (2010, 2015 & 2020) by Country for Brazil, Mexico and Rest of Latin America (Graphical Representation Included)
3.13.4.5 (I) Brazilian PET Bioimaging Market
3.13.4.5 (II) Mexican PET Bioimaging Market
Exhibit 111. List of Major Latin-America PET Bioimaging Companies
3.13.4.6 Rest of World PET Bioimaging Market
Exhibit 112. PET Bioimaging – Rest of World Market Estimations & Predictions (2005-2020) by Country for Israel, South Africa and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 113. PET Bioimaging – Rest of World Market Shares (2010, 2015 & 2020) by Country for Israel, South Africa and Other Countries (Graphical Representation Included)
3.13.4.6 (I) Israeli PET Bioimaging Market
3.13.4.6 (II) South African PET Bioimaging Market
Exhibit 114. List of Major Rest of World PET Bioimaging Companies
3.13.5 SPECT (Single-Photon Emission Computed Tomography)
3.13.5.1 Global SPECT Bioimaging Market
Exhibit 115. SPECT Bioimaging – Global Market Estimations & Predictions (2005 – 2020) by Geographic Region for North America, Europe, Asia-Pacific, Latin America and Rest of World (RoW) in US$ Million (Graphical Representation Included)
Exhibit 116. SPECT Bioimaging – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific, Latin America and Rest of World (RoW) (Graphical Representation Included)
3.13.5.2 North American SPECT Bioimaging Market
Exhibit 117. SPECT Bioimaging – North American Market Estimations & Predictions (2005 – 2020) by Country for the United States and Canada in US$ Million (Graphical Representation Included)
Exhibit 118. SPECT Bioimaging – North American Market Shares (2010, 2015 & 2020) by Country for the United States and Canada (Graphical Representation Included)
3.13.5.2 (I) US SPECT Bioimaging Market
3.13.5.2 (II) Canadian SPECT Bioimaging Market
Exhibit 119. List of Major North American SPECT Bioimaging Companies
3.13.5.3 European SPECT Bioimaging Market
Exhibit 120. SPECT Bioimaging – European Market Estimations & Predictions (2005 – 2020) by Country for Germany, United Kingdom, France, Italy, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 121. SPECT Bioimaging – European Market Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, France, Italy, Russia and Rest of Europe (Graphical Representation Included)
3.13.5.3 (I) German SPECT Bioimaging Market
3.13.5.3 (II) UK SPECT Bioimaging Market
3.13.5.3 (III) French SPECT Bioimaging Market
3.13.5.3 (IV) Italian SPECT Bioimaging Market
3.13.5.3 (V) Russian SPECT Bioimaging Market
Exhibit 122. List of Major European SPECT Bioimaging Companies
3.13.5.4 Asia-Pacific SPECT Bioimaging Market
Exhibit 123. SPECT Bioimaging – Asia-Pacific Market Estimations & Predictions (2005-2020) in US$ Million by Country for Australia, China, India, Japan, South Korea and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Exhibit 124. SPECT Bioimaging – Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Australia, China, India, Japan, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
3.13.5.4 (I) Australian SPECT Bioimaging Market
3.13.5.4 (II) Chinese SPECT Bioimaging Market
3.13.5.4 (III) Indian SPECT Bioimaging Market
3.13.5.4 (IV) Japanese SPECT Bioimaging Market
3.13.5.4 (II) South Korean SPECT Bioimaging Market
Exhibit 125. List of Major Asia-Pacific SPECT Bioimaging Companies
3.13.5.5 Latin American SPECT Bioimaging Market
Exhibit 126. SPECT Bioimaging – Latin American Market Estimations & Predictions (2005 – 2020) by Country for Brazil, Mexico and Rest of Latin America in US$ Million (Graphical Representation Included)
Exhibit 127. SPECT Bioimaging – Latin American Market Shares (2010, 2015 & 2020) by Country for Brazil, Mexico and Rest of Latin America (Graphical Representation Included)
3.13.5.5 (I) Brazilian SPECT Bioimaging Market
3.13.5.5 (II) Mexican SPECT Bioimaging Market
Exhibit 128. List of Major Latin-America SPECT Bioimaging Companies
3.13.5.6 Rest of World SPECT Bioimaging Market
Exhibit 129. SPECT Bioimaging – Rest of World Market Estimations & Predictions (2005-2020) by Country for Israel,
South Africa and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 130. SPECT Bioimaging – Latin Rest of World (2010, 2015 & 2020) by Country for Israel, South Africa and Other Countries (Graphical Representation Included)
3.13.5.6 (I) Israeli SPECT Bioimaging Market
3.13.5.6 (II) South AfricaanSPECT Bioimaging Market
Exhibit 131. List of Major Rest of World SPECT Bioimaging Companies
3.13.6 Other Bioimaging Modalities
3.13.6.1 Global Other Bioimaging Modalities Market
Exhibit 132. Other Bioimaging Modalities – Global Market Estimations & Predictions (2005 – 2020) by Geographic Region for North America, Europe, Asia-Pacific, Latin America and Rest of World (RoW) in US$ Million (Graphical Representation Included)
Exhibit 133. Other Bioimaging Modalities – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific, Latin America and Rest of World (RoW) (Graphical Representation Included)
3.13.6.2 North American Other Bioimaging Modalities Market
Exhibit 134. Other Bioimaging Modalities – North American Market Estimations & Predictions (2005 – 2020) by Country for the United States and Canada in US$ Million (Graphical Representation Included)
Exhibit 135. Other Bioimaging Modalities – North American Market Shares (2010, 2015 & 2020) by Country for the United States and Canada (Graphical Representation Included)
3.13.6.3 European Other Bioimaging Modalities Market
Exhibit 136. Other Bioimaging Modalities – European Market Estimations & Predictions (2005 – 2020) by Country for Germany, United Kingdom, France, Italy, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 137. Other Bioimaging Modalities – European Market Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, France, Italy, Russia and Rest of Europe (Graphical Representation Included)
3.13.6.4 Asia-Pacific Other Bioimaging Modalities Market
Exhibit 138. Other Bioimaging Modalities – Asia-Pacific Market Estimations & Predictions (2005-2020) in US$ Million by Country for Australia, China, India, Japan, South Korea and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Exhibit 139. Other Bioimaging Modalities – Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Australia, China, India, Japan, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
3.13.6.5 Latin American Other Bioimaging Modalities Market
Exhibit 140. Other Bioimaging Modalities – Latin American Market Estimations & Predictions (2005 – 2020) by Country for Brazil, Mexico and Rest of Latin America in US$ Million (Graphical Representation Included)
Exhibit 141. Other Bioimaging Modalities – Latin American Market Shares (2010, 2015 & 2020) by Country for Brazil, Mexico and Rest of Latin America (Graphical Representation Included)
3.13.6.6 Rest of World Other Bioimaging Modalities Market
Exhibit 142. Other Bioimaging Modalities – Rest of World Market Estimations & Predictions (2005-2020) by Country for Israel, South Africa and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 143. Other Bioimaging Modalities – Rest of World Market Shares (2010, 2015 & 2020) by Country for Israel, South Africa and Other Countries (Graphical Representation Included)
3.14 Bioimaging – Market Outlook
4. PRODUCT TECHNOLOGY/RESEARCH
4.1Introduction
Imaging Techniques
Imaging Techniques in Drug Development
Digital Imaging
Digital Image Processing
1. Image
2. Digital Images
3. Digital Image Processing Systems
4. Analog vs. Digital Images
5. Converting from Analog Image to Digital Image
6. Color and Grayscale Images
7. Digital Image Processing (DIP) System
8. Digital Image Processing Steps
Principles of Diagnostic Imaging Tools
1. Magnetic Resonance Imaging
A. Single Photon Emission Computed Tomography
B. Computed Tomography
The Present Day Imaging Technology
Fluoroscopy Techniques
Structure and Set Up of Initial Fluoroscope Design
X-Ray Image Intensifiers: An Apparatus to View Images under Normal Light
Flat-Panel Detectors: A Replacement for Image Intensifiers
Medical Imaging
Medical Imaging Fluoroscopy – Advantages
Molecular Imaging
Enhancements in Cancer through Molecular Imaging
The Functionality of Operational Molecular Imaging in Cancer
Role of PET in Molecular Imaging in Relation to Cancer
Molecular Imaging Usage in Improvising Cancer Therapeutics
Application of Molecular Imaging in Chemotherapy
Molecular Imaging in Neurology
PET based Molecular Imaging for Neurological Ailments
Prospects for Molecular Neuroimaging
Diagnostic
Molecular Imaging of the Lungs
Molecular Imaging of Musculoskeletal Diseases
Molecular Imaging of the Kidneys with PET
Molecular Imaging of Antiangiogenic Agents
Craniofacial Scanning
Chest Scanning
Cardiac Scanning
Abdominal Scanning
Pelvis Scanning
Research and Development
Functional Imaging in Drug Discovery and Development
Role of Imaging Biomarkers in the Discovery and Development of Cancer Drugs
Advantages of Biomarkers
Reporter Mice and Drug Discovery and Development
The Potential of High-Content High-Throughput Microscopy in Drug Discovery
Noninvasive Imaging of Melanoma with Reflectance Mode Confocal Scanning Laser Microscopy
Dynamic Imaging of Chemokine-Dependent CD8+ T cell Help for CD8+ T cell Responses
Functional Genomics and Radioisotope-Based Imaging Procedures
Imaging and Oncologic Drug Development
The Role of Bioimaging in Drug Discovery
Clinical Biomarkers in Drug Discovery and Development
Using Imaging Biomarkers to Accelerate Drug Development and Clinical Trials
Pharmacodynamic Biomarkers for Molecular Cancer Therapeutics
Development and Use of Biomarkers in Oncology Drug Development
Biomedical /Medico Related Benefits in R&D via Biomarkers
Right Parietal Dysfunction in Children with Attention Deficit Hyperactivity Disorder,
Combined Type A Functional MRI Study
Molecular, Cellular and Functional Imaging of Atherothrombosis
Quantum Dots: Superior Alternative in Bioimaging Technology
4.2 Segmentation by Modalities
Ultrasound
Ultrasound – Types
3D Ultrasound
Ultrasonography
Modes of Sonography
CT
Computed Tomography
Tomosynthesis
Types of Acquisition
MRI
Magnetic Resonance Imaging (MRI): The Latest Advancements in the Imaging Technology
i. Diffusion Magnetic Resonance Imaging
ii. Magnetic Resonance Angiography
iii. Magnetic Resonance Spectroscopy
iv. Functional Magnetic Resonance Imaging
PET
Positron Emission Tomography
SPECT
Applications of Single Photon Emission Computed Tomography (SPECT)
Other Modalitites
Projection Radiography
Mammography
Dental Radiography
Digital Radiography
Other Detection Devices
Geiger Counter
Scintillators
Fluoroscopy
Energy Dispersive X-Ray Spectroscopy
Electron Microscopes for Bioimaging
Bioimaging Procedures being used or Developed for Generating 3D Images
Types of Tomography
Based on Movement
Based on Principle of Working
Single Point Optical Coherence Tomography
Parallel Optical Coherence Tomography
Fluorescence Lifetime Imaging
Gallium Imaging
Optoacoustic Imaging
Photoacoustic Imaging
Diffusion-Weighted Imaging
Bioluminescence Imaging
Calcium Imaging
Diagnostic Imaging Agents
Exhibit 144. Imaging Agents – Global Market Estimations & Predictions (2005 – 2020) by Geographic Region for the North America, Japan, Europe and Rest of World in US$ Billion (Graphical Representation Included)
Exhibit 145. Imaging Agents – Global Market Shares (2010, 2015 & 2020) by Geographic Region for the North America, Japan, Europe and Rest of World (Graphical Representation Included)
Exhibit 146. Therapeutic and Diagnostic Imaging Antibodies – Global Market Estimations & Predictions (2005 – 2020) in US$ Billion (Graphical Representation Included)
Neuroimaging
Basics of Brain Imaging
Computed Axial Tomography
Magnetic Resonance Imaging
Working of MRI
Functional Magnetic Resonance Imaging
fMRI Technique: Mixture of Technical and Medical Fields
Advantages of fMRI
Other Techniques
Contrast MR
Arterial Spin Labeling
Magnetic Resonance Spectroscopic Imaging
Diffusion Tensor Imaging
Positro Emission Tomography
Molecular Neuroimaging
Latest Technologies in Neuroimaging
Radioactivity and Brain Imaging
Multimodal Neuroimaging
Functional Brain Imaging
Neuroimaging for Neuropsychiatry
Diagnosing and Treating Neuroendocrine Tumors
Neuropharmacology and Drug Development
Spontaneous Fluctuations in Brain Activity Observed with Functional Magnetic Resonance Imaging
Role of Neuroimaging in Alzheimer's Disease, with Emphasis on Brain Perfusion SPECT
Treatment for Behavioural Disorders in Neurodegenerative Diseases:
Drug Development Strategies
Computational Bioimaging
Bioimaging Software
Neuroimaging Software
Digital Signal Processing (DSP)
Optimization and Advantages of FPGA
Standardized Digital Photography in Medicine
Consistent Photo Documentation for Clinical Trials
Biosoftware Dermoscope
Grid-based Computer-Aided Detection System (Grid CAD)
Computational Genomics Research – Advantages
Intervention Magnetic Character Imaging
Radiation Cure Reproduction
Current Density Imaging
High Powered Magnetic Character Concentrated Ultrasound Function
Multinucleate Imaging
Anlytical Magnetic Character Imaging Techniques
Interpretation and Interpolation of Data using Imaging
Hurdles Encountered During Imaging
4.3 Bioimaging - Research Briefs
Compression ultrasound for DVT
CT Scan for Abdominal Pain
Elastography for Breast Cancer
Ultrasound Methodology for Ovarian Cancer
Merging SPECT-CT images in Breast Cancer Treatment
XFEL for Membrane Protein Structure
Urological Study Showed Stereotactic Biopsy System Delivered Greater Accuracy in Detecting Cancer and Planning for Targeted Prostate Cancer Therapies
Targeted Prostate Cancer Biopsy and Cancer Treatment has been Accepted by Nations
More…
5. CORPORATE DIRECTORY
6. PATENTS INFORMATION

To request a free sample copy of this report, please complete the form below.

Enter captcha code*

We never share your personal data. Privacy policy